4-Nitrophenylboronic Acid (contains varying amounts of Anhydride) ≥95%
N136136-100G / 100G
CAS:24067-17-2
4-Nitrophenylboronic Acid (contains varying amounts of Anhydride) ≥95%
N136136-10G / 10G
CAS:24067-17-2
4-Nitrophenylboronic Acid (contains varying amounts of Anhydride) ≥95%
N136136-1G / 1G
CAS:24067-17-2
4-Nitrophenylboronic Acid (contains varying amounts of Anhydride) ≥95%
N136136-25G / 25G
CAS:24067-17-2
4-Nitrophenylboronic Acid (contains varying amounts of Anhydride) ≥95%
N136136-5G / 5G
CAS:24067-17-2
N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine Moligand™, ≥98%(HPLC)
N136726-100MG / 100MG
CAS:73029-73-9
N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine Moligand™, ≥98%(HPLC)
N136726-10MG / 10MG
CAS:73029-73-9
N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine Moligand™, ≥98%(HPLC)
N136726-1MG / 1MG
CAS:73029-73-9
N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine Moligand™, ≥98%(HPLC)
N136726-25MG / 25MG
CAS:73029-73-9
N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine Moligand™, ≥98%(HPLC)
N136726-50MG / 50MG
CAS:73029-73-9
N-Cyclohexyl-N-[2-(3,5-dimethyl-pyrazol-1-yl)-6-methyl-4-pyrimidinamine Moligand™, ≥98%(HPLC)
N136726-5MG / 5MG
CAS:73029-73-9